SURGICAL
Long-Term Efficacy of Risk-Directed, De-Escalated Post-Operative Adjuvant Therapy for Surgically Resected Locally Advanced, Human Papillomavirus-Positive Oropharynx Squamous-Cell Carcinoma (HPV+ OPSCC): A Non-Randomized, Multi-Arm Phase 2 Trial
Wade L. Thorstad, Ryan S. Jackson, Peter Oppelt, Patrik Pipkorn, Jason T. Rich, Jessica Ley, Brianne Thomeczek, Jingxia Liu, José P. Zevallos, S. Puram, D. Adkins
- Year
- 2024
- Citations
- 5
Keywords
MedicineHuman papillomavirusOncologyAdjuvantRandomized controlled trialBasal cellInternal medicineAdjuvant therapySurgeryCancer
Related papers
OTHER
📊 3,417 cites
Robots and Jobs: Evidence from US Labor Markets
Daron Acemoğlu, Pascual Restrepo
2019
MANIPULATION
Open access📊 2,730 cites
Reach and grasp by people with tetraplegia using a neurally controlled robotic arm
Leigh R. Hochberg, Daniel Bacher, Beata Jarosiewicz +8 more
2012
SURGICAL
📊 2,712 cites
Campbell-Walsh urology
Alan J. Wein editor-in-chief
2012
OTHER
📊 2,587 cites
Stroke rehabilitation
Peter Langhorne, Julie Bernhardt, Gert Kwakkel
2011